» Articles » PMID: 15659746

Dendritic-cell Infection by Human Cytomegalovirus is Restricted to Strains Carrying Functional UL131-128 Genes and Mediates Efficient Viral Antigen Presentation to CD8+ T Cells

Overview
Journal J Gen Virol
Specialty Microbiology
Date 2005 Jan 22
PMID 15659746
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Human cytomegalovirus (HCMV) genetic determinants of endothelial-cell tropism and virus transfer to leukocytes (both polymorphonuclear and monocyte) have been recently identified in the UL131-128 genes. Here it is documented that the same genetic determinants of HCMV are responsible for monocyte-derived dendritic-cell (DC) tropism, i.e. all endotheliotropic and leukotropic strains of HCMV are also DC-tropic (or dendrotropic). In fact, all recent clinical HCMV isolates and deletion mutants sparing the UL131-128 locus as well as the endotheliotropic revertants AD169 and Towne were able to productively infect DC following co-culture with infected endothelial cells. On the contrary, the same clinical isolates extensively propagated in human fibroblasts, the UL131-128 deletion mutants and the reference laboratory strains were not. Peak extracellular virus titres in DC were reached 4-7 days post-infection (p.i.). Viral proteins pp65 and p72 were detected 1-3 h p.i., involving the great majority of DC 24 h p.i., while gB was abundantly detected 96 h p.i., when a cytopathic effect first appeared. Infection of DC with cell-free virus released into the medium could only be achieved with HCMV strains extensively adapted to growth in endothelial cells, reaching the peak titres 10 days p.i. DC infected for 24 h with cell-free virus and incubated for 16 h with autologous peripheral blood mononuclear cells were found to act as a potent stimulator of both HCMV-specific CD4+- and CD8+-mediated immune responses, as determined by cytokine flow cytometry. DC incubated with inactivated crude whole viral antigen preparations were only capable of eliciting a significant CD4+-mediated immune response.

Citing Articles

Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation.

Sponholtz M, Byrne P, Lee A, Ramamohan A, Goldsmith J, McCool R Proc Natl Acad Sci U S A. 2024; 121(37):e2404250121.

PMID: 39231203 PMC: 11406251. DOI: 10.1073/pnas.2404250121.


Inhibition of human cytomegalovirus entry into mucosal epithelial cells.

He L, Hertel L, James C, Morgan I, Klingelhutz A, Fu T Antiviral Res. 2024; 230:105971.

PMID: 39074588 PMC: 11408113. DOI: 10.1016/j.antiviral.2024.105971.


Dissecting the cytomegalovirus CC chemokine: Chemokine activity and gHgLchemokine-dependent cell tropism are independent players in CMV infection.

Eletreby M, Thiessen L, Prager A, Brizic I, Materljan J, Kubic L PLoS Pathog. 2023; 19(12):e1011793.

PMID: 38064525 PMC: 10732436. DOI: 10.1371/journal.ppat.1011793.


Fibroblast, Epithelial and Endothelial Cell-Derived Human Cytomegalovirus Strains Display Distinct Neutralizing Antibody Responses and Varying Levels of gH/gL Complexes.

Fornara C, Schultz E, Lilleri D, Baldanti F, Ryckman B, Gerna G Int J Mol Sci. 2023; 24(5).

PMID: 36901847 PMC: 10003051. DOI: 10.3390/ijms24054417.


Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas.

Tabata T, Petitt M, Li J, Chi X, Chen W, Yurgelonis I Vaccines (Basel). 2022; 10(7).

PMID: 35891239 PMC: 9315547. DOI: 10.3390/vaccines10071074.